Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Acute transverse myelitis (ascending myelitis) as the initial manifestation of Japanese encephalitis: a rare presentation.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
Does Infection-Induced Immune Activation Contribute to Dementia?
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Changes of Cine Cerebrospinal Fluid Dynamics in Patients with Multiple Sclerosis Treated with Percutaneous Transluminal Angioplasty: Case-control Study.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
[Every fifth case of multiple sclerosis is familial.]
Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria.
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
Recall strategies for the verbal fluency test in patients with multiple sclerosis.
Explaining, not just predicting, drives interest in personal genomics.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
[The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.
Sarcoidosis associated with neuromyelitis optica.
Magnetic resonance spectroscopy findings as related to fatigue and cognitive performance in multiple sclerosis patients with mild disability.
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »